NR3C1 and gastric cancer: NR3C1 expression and IC50 values were tested in eight patient‐derived organoids (PDOs) constructed from patients with GC (numbered P1‐P8) (Figure 3F,G, Figure S4D,E, Supporting Information), indicating that NR3C1 expression was positively correlated with 5‐FU IC50 values in the organoids (R2 = 0.596, p = 0.0248, Figure 3H).